These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Clinical significance of measurement of free light chains]. Matsuda M Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770 [TBL] [Abstract][Full Text] [Related]
6. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma. Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439 [TBL] [Abstract][Full Text] [Related]
7. Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders. Vanderboom PM; Chawla Y; Dasari S; Kapoor I; Kumar SK; Nair KS; Gonsalves WI Eur J Haematol; 2024 May; ():. PubMed ID: 38804098 [TBL] [Abstract][Full Text] [Related]
8. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management. Rajkumar SV Hematology Am Soc Hematol Educ Program; 2005; ():340-5. PubMed ID: 16304401 [TBL] [Abstract][Full Text] [Related]
19. Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies. Cigliana G; Torti E; Gulli F; De Santis E; Dell'Abate MT; Colacicco L; Pisani F; Conti L; Basile U J Exp Clin Cancer Res; 2015 Apr; 34(1):37. PubMed ID: 26025441 [TBL] [Abstract][Full Text] [Related]
20. Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication. Tong M; Kleffmann T; Pradhan S; Johansson CL; DeSousa J; Stone PR; James JL; Chen Q; Chamley LW Hum Reprod; 2016 Apr; 31(4):687-99. PubMed ID: 26839151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]